Sulforaphane-rich broccoli sprout extract improves hepatic abnormalities in male subjects
Masahiro Kikuchi, Hirokazu Shiozawa, Rumiko Umeda, Kota Tsuruya, Digestive and Liver Disease Center, Tokai University Tokyo Hospital, Tokyo 153-0065, Japan
Yusuke Ushida, Yudai Aoki, Hiroyuki Suganuma, Research and Development Division, Kagome Co., Ltd., 17 Nishitomiyama, Nasushiobara, Tochigi 329-2762, Japan
Yasuhiro Nishizaki, Department of Clinical Health Science, Tokai University Tokyo Hospital, Tokyo 153-0065, Japan
Author contributions: Kikuchi M, Ushida Y, Shiozawa H, Aoki Y, Suganuma H and Nishizaki Y designed the research; Kikuchi M, Umeda R, Tsuruya K, Shiozawa H and Nishizaki Y performed clinical research; Ushida Y contributed to biological analyses and preformed animal experiments; Kikuchi M and Nishizaki Y interpreted the data; Kikuchi M, Ushida Y and Nishizaki Y wrote the paper.
Institutional review board statement: The clinical trial has been registered with UMIN-CTR (#UMIN000012855); the protocol was approved by the Institutional Review Board for Clinical Research of the Tokai University School of Medicine (#13R-169) and the Ethics Committee of Kagome Co., Ltd (#2013-R05); the study was conducted in accordance with the International Ethical Guidelines and Declaration of Helsinki.
Institutional animal care and use committee statement: The animal experiment was approved by the Animal Care and Use Committee of Kagome Co., Ltd. in accordance with the guidelines established by the Japanese Society of Nutrition and Food Science (Law and Notification 6 of the Japanese Government). The animal experiment was designed to minimize pain or discomfort to the animals.
Conflict-of-interest statement: This study was sponsored by Kagome Co., Ltd. The authors declare no conflict of interest associated with this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Yasuhiro Nishizaki, MD, PhD, Professor, Department of Clinical Health Science, Tokai University Tokyo Hospital, 1-2-5, Yoyogi, Shibuya-ku, Tokyo 153-0065, Japan. email@example.com
Telephone: +81-3-33702321 Fax: +81-3-5354-5366
Received: June 17, 2015
Peer-review started: June 19, 2015
First decision: July 19, 2015
Revised: August 7, 2015
Accepted: September 13, 2015
Article in press: September 14, 2015
Published online: November 21, 2015